Molecular Partners Correlations

MOLN Stock

USD 4.25 0.05 1.19%

The current 90-days correlation between Molecular Partners and MediciNova is 0.1 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Molecular Partners moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Molecular Partners AG moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Molecular Partners Correlation With Market

Very weak diversification

The correlation between Molecular Partners AG and DJI is 0.46 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Molecular Partners AG. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Moving together with Molecular Stock

0.64	CLDX	Celldex Therapeutics	Pair Corr
0.69	GKOS	Glaukos Corp	Pair Corr
0.68	ITGR	Integer Holdings Corp	Pair Corr
0.69	LIVN	LivaNova PLC	Pair Corr
0.64	MODD	Modular Medical	Pair Corr
0.7	APYX	Apyx Medical	Pair Corr
0.71	SRDX	SurModics	Pair Corr
0.68	CNMD	CONMED	Pair Corr

Moving against Molecular Stock

0.78	CMRX	Chimerix Sell-off Trend	Pair Corr
0.67	CPIX	Cumberland Pharmaceuticals	Pair Corr
0.64	FNA	Paragon 28	Pair Corr
0.68	LUCD	Lucid Diagnostics Buyout Trend	Pair Corr
0.58	NVRO	Nevro Corp	Pair Corr
0.53	LUNG	Pulmonx Corp	Pair Corr
0.51	INMD	InMode	Pair Corr
0.75	FWEDF	Fireweed Zinc	Pair Corr
0.73	BRK-A	Berkshire Hathaway	Pair Corr
0.73	BRK-B	Berkshire Hathaway	Pair Corr
0.66	NHNCF	NAVER Corp	Pair Corr
0.49	PKX	POSCO Holdings	Pair Corr
0.43	TOI	Oncology Institute Earnings Call This Week	Pair Corr

Related Correlations Analysis

	MLYS	ANTX	PHVS	PEPG	MNOV	ANEB	CSBR	RZLT	HCWB	PMVP
MLYS		0.79	0.14	0.44	-0.1	0.28	-0.45	-0.43	-0.08	-0.05	MLYS
ANTX	0.79		0.34	0.75	0.14	0.27	-0.66	-0.26	-0.17	0.15	ANTX
PHVS	0.14	0.34		0.45	0.79	0.38	-0.33	0.58	0.24	0.68	PHVS
PEPG	0.44	0.75	0.45		0.48	-0.07	-0.87	-0.02	0.05	0.56	PEPG
MNOV	-0.1	0.14	0.79	0.48		0.19	-0.4	0.7	0.31	0.9	MNOV
ANEB	0.28	0.27	0.38	-0.07	0.19		0.17	0.34	0.02	0.11	ANEB
CSBR	-0.45	-0.66	-0.33	-0.87	-0.4	0.17		0.15	-0.09	-0.48	CSBR
RZLT	-0.43	-0.26	0.58	-0.02	0.7	0.34	0.15		0.4	0.65	RZLT
HCWB	-0.08	-0.17	0.24	0.05	0.31	0.02	-0.09	0.4		0.37	HCWB
PMVP	-0.05	0.15	0.68	0.56	0.9	0.11	-0.48	0.65	0.37		PMVP
	MLYS	ANTX	PHVS	PEPG	MNOV	ANEB	CSBR	RZLT	HCWB	PMVP

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

PMVP	+ 0.9	MNOV
ANTX	+ 0.79	MLYS
MNOV	+ 0.79	PHVS
PEPG	+ 0.75	ANTX
RZLT	+ 0.7	MNOV
PMVP	+ 0.68	PHVS

High negative correlations

CSBR	- 0.87	PEPG
CSBR	- 0.66	ANTX
PMVP	- 0.48	CSBR
CSBR	- 0.45	MLYS
RZLT	- 0.43	MLYS
CSBR	- 0.4	MNOV

Risk-Adjusted Indicators

There is a big difference between Molecular Stock performing well and Molecular Partners Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Molecular Partners' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
MLYS	4.39	0.48	0.14	(0.37)	4.39	(5.10)	10.04	(8.23)	50.53
ANTX	2.47	(0.01)	0.00	(0.08)	0.00	0.00	5.41	(4.39)	17.09
PHVS	2.23	(0.26)	0.00	4.28	0.00	0.00	5.21	(3.84)	14.29
PEPG	8.29	(0.39)	0.00	(0.21)	0.00	0.00	19.62	(13.91)	92.48
MNOV	2.22	(0.42)	0.00	(0.62)	0.00	0.00	5.35	(5.24)	16.27
ANEB	5.46	0.99	0.17	0.60	4.76	(7.55)	19.58	(9.76)	40.87
CSBR	4.69	1.13	0.21	0.68	4.61	(5.38)	10.00	(8.29)	33.14
RZLT	3.06	(0.45)	0.00	(0.54)	0.00	0.00	5.62	(6.49)	22.04
HCWB	6.65	0.53	0.08	(0.91)	6.34	(12.78)	9.76	(14.29)	148.94
PMVP	1.81	(0.21)	0.00	(0.27)	0.00	0.00	4.41	(3.31)	16.42

Molecular Partners Corporate Management

Robert Hendriks	Senior Finance	Profile
Alexander Zurcher	COO Board	Profile
Michael Pitzner	Compliance Counsel	Profile
MD MBA	Interim Officer	Profile
Daniel Steiner	Senior Technology	Profile
Anne DVM	Senior Development	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC